e-learning
resources
Virtual 2020
Pre-Congress Content
Biological mechanisms of lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lung Micobiome in Lung Cancer
J. Vengoechea (Zaragoza, Spain), M. Ponce-Alonso (Madrid, Spain), A. Figueredo (Zaragoza, Spain), E. Mincholé (Zaragoza, Spain), R. Del Campo (Madrid, Spain), S. Bello (Zaragoza, Spain)
Source:
Virtual Congress 2020 – Biological mechanisms of lung cancer
Session:
Biological mechanisms of lung cancer
Session type:
E-poster session
Number:
1770
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Vengoechea (Zaragoza, Spain), M. Ponce-Alonso (Madrid, Spain), A. Figueredo (Zaragoza, Spain), E. Mincholé (Zaragoza, Spain), R. Del Campo (Madrid, Spain), S. Bello (Zaragoza, Spain). Lung Micobiome in Lung Cancer. 1770
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
Lung Microbiota and Streptococcal enrichment in Central Lung Cancer
Source: Virtual Congress 2020 – Biological mechanisms of lung cancer
Year: 2020
Lung Cancer and bronchial infection
Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes
Year: 2017
Pretreatment Evaluation on Non-Small-cell Lung Cancer
Source: Guideline 1997
Year: 1997
Effect of the Liverpool Healthy Lung Programme on Outcomes in Lung Cancer
Source: Virtual Congress 2020 – Screening and early lung cancer
Year: 2020
The Burden of Asymptomatic Lung Cancer
Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer
Year: 2019
Symptom-to-treatment intervals in lung cancer
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014
Lung Cancer vs. „Young Cancer“ – Is There a Difference?
Source: Virtual Congress 2021 – COVID-19 and management of lung cancer
Year: 2021
The Role Of TGF-ß in Lung Cancer Development in COPD Patients
Source: Virtual Congress 2020 – Biological mechanisms of lung cancer
Year: 2020
Lung cancer in women: Is it different?
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014
Determinants of Respiratory Muscle Strength in Lung Cancer
Source: International Congress 2019 – New views on testing and training of respiratory muscles
Year: 2019
Lung Volume Reduction Surgery for Emphysema
Source: Eur Respir J 2004; 24 : 713
Year: 2004
Pathology of Vaping-Associated Lung Injury
Source: Virtual Congress 2020 – E-cigarette or Vaping, product use Associated Lung Injury (EVALI)
Year: 2020
Increase in hospital admissions in smokers with Interstitial Lung Abnormalities in the Danish Lung Cancer Screening Trial (DLCST)
Source: International Congress 2018 – COPD and chronic respiratory disease: from misclassification to radiological findings
Year: 2018
Resected Non-Small Cell Lung Cancer : A 5-year Experience
Source: Virtual Congress 2020 – Localised non-small cell lung cancer
Year: 2020
Chaperone-Mediated Autophagy-Dependent Chemoresistance in Non-Small Cell Lung Cancer
Source: International Congress 2019 – Novel molecular pathways in lung cancer and COPD
Year: 2019
Lung tumours
Source: Eur Respir Monogr 2018; 79: 115-128
Year: 2018
Lung cancer
Source: School Course 2014 - Pulmonary Rehabilitation
Year: 2014
Lung cancer
Source: Breathe 2016; 12: 392-399
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept